United States · FDA National Drug Code directory
Carbidopa and Levodopa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-460_2009b0d7-8e85-45c3-b223-c30ef535d90b
- Product NDC
- 50228-460
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Carbidopa and Levodopa
- Labeler
- ScieGen Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211005
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 25 mg/1
- LEVODOPA — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-01) · 50228-460-01
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-10) · 50228-460-10
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-30) · 50228-460-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →